Toagosei (4045) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
10 Mar, 2026Executive summary
Net sales for the six months ended June 30, 2024, rose 6.0% year-over-year to ¥81,571 million, driven by recovery in shipment volumes for commodity chemicals and electronic component products.
Operating income increased 54.3% year-over-year to ¥7,323 million.
Net income attributable to owners of parent grew 41.9% year-over-year to ¥7,041 million.
Annual dividend for FY2024 is set to increase by 7 yen to 60 yen per share, with an interim dividend of 30 yen and a year-end dividend of 30 yen.
Comprehensive income for the period was ¥12,978 million, up 30.0% year-over-year.
Financial highlights
Ordinary profit for the six months was ¥8,758 million, a 24.3% increase year-over-year.
Diluted earnings per share for the period were ¥61.52, up from ¥45.71 in the prior year.
Free cash flow decreased to ¥4,192 million from ¥9,153 million year-over-year due to higher investment activities.
Total assets as of June 30, 2024, were ¥280,939 million, up from ¥272,285 million at year-end 2023.
Net assets increased to ¥216,991 million from ¥212,518 million at year-end 2023.
Outlook and guidance
FY2024 full-year net sales forecast at ¥170,000 million, up ¥10,629 million from FY2023.
Operating income projected to reach ¥15,500 million, up ¥3,001 million year-over-year.
Net income attributable to owners of parent forecast at ¥12,800 million, a 5.1% increase year-over-year.
Earnings per share for the full year are expected to be ¥112.77.
Annual dividend forecast at 60 yen per share; share repurchase limit increased by ¥1 billion to ¥7 billion.
Latest events from Toagosei
- FY2024 saw higher sales, profits, and dividends, with FY2025 targeting further profit growth.4045
Q4 202410 Mar 2026 - Strong sales, profit, and EPS growth with robust 2024 guidance and stable dividend.4045
Q3 202410 Mar 2026 - Net sales rose 2.1% year-over-year, but profits fell and dividend forecast increased amid uncertainty.4045
Q1 202510 Mar 2026 - Sales and profits fell, outlook was lowered, and U.S. adhesives business was restructured.4045
Q2 202510 Mar 2026 - Net sales and profits fell year-over-year, but the dividend payout is set to rise.4045
Q3 202510 Mar 2026 - Net sales fell but net income rose on asset sales; FY2026 targets modest growth and strong returns.4045
Q4 202510 Mar 2026